Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Clinical Trial to Examine the Role of Rosuvastatin and Exercise Treatment in Modulating Inflammatory Response in Hypercholesterolemic Subjects

NCT00295373 is registered in ClinicalTrials.gov with Purdue University as lead sponsor.

NCT NCT00295373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00295373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Clinical Trial to Examine the Role of Rosuvastatin and Exercise Treatment in Modulating Inflammatory Response in Hypercholesterolemic Subjects
Lead sponsor
Purdue University
Phase
Phase 4
Overall status
Unknown status
Start date
February 28, 2006
Completion date
August 31, 2007
Enrollment
48
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonfamilial hypercholesterolemia, physical inactivity